SM
TMBR

Sabby Management’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Sabby Management’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,994
Closed -$22.7K – 139
2022
Q4 		$22.7K Buy
+12,994
New +$31.6K 0.02% 95
2018
Q1 		– Sell
-448
Closed -$740K – 199
2017
Q4 		$740K Buy
+448
New +$1.22M 0.07% 90
2017
Q1 		– Sell
-47
Closed -$265K – 338
2016
Q4 		$265K Buy
47
+3
+7% +$15.3K 0.02% 232
2016
Q3 		$363K Sell
44
-20
-31% -$211K 0.01% 244
2016
Q2 		$622K Buy
64
+12
+23% +$135K 0.03% 200
2016
Q1 		$845K Buy
+52
New +$1.18M 0.04% 168

Other funds holding TMBR

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sabby Management's TMBR Position: Q1 2023 in Review

Sabby Management sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2023, closing a stake of 12,994 shares — an estimated $22.7K sold.

Sabby Management first reported a position in TMBR in Q1 2016 and held it in 6 quarters. The position peaked at $845K in Q1 2016. 13 funds tracked by Wall St. Rank hold TMBR as of Q1 2023.

  • Sabby Management reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Sabby Management sold 12,994 Timber Pharmaceuticals, Inc. shares in Q1 2023, an estimated $22.7K.
  • Sabby Management first reported a position in Timber Pharmaceuticals, Inc. in Q1 2016 and held it in 6 quarters.
  • Sabby Management's Timber Pharmaceuticals, Inc. position peaked at $845K in Q1 2016.
  • 13 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2023.

Based on Sabby Management's 13F filing for Q1 2023, filed 15 May 2023.